Filter Results
:
(559)
Show Results For
-
All HBS Web
(3,258)
- Faculty Publications (559)
Show Results For
-
All HBS Web
(3,258)
- Faculty Publications (559)
- January 2001
- Case
Merck Global Health Initiatives (A)
By: James E. Austin, Diana Barrett and James Weber
The case series focuses on Merck's drug donation program and then raises new issues facing management about what to do about HIV/AIDS in Africa given the company's development of a new therapy. Describes collaboration among many parties including the Gates Foundation,...
View Details
Keywords:
Programs;
Philanthropy and Charitable Giving;
Health Disorders;
Health Care and Treatment;
Private Sector;
Public Sector;
Alliances;
Problems and Challenges;
Pharmaceutical Industry;
Botswana
Austin, James E., Diana Barrett, and James Weber. "Merck Global Health Initiatives (A)." Harvard Business School Case 301-088, January 2001.
- January 2001
- Case
Merck Global Health Initiatives (B): Botswana
By: James E. Austin, Diana Barrett and James Weber
The case series focuses on Merck's drug donation program and then raises new issues facing management about what to do about HIV/AIDS in Africa given the company's development of a new therapy. Describes collaboration among many parties including the Gates Foundation,...
View Details
Keywords:
Health Disorders;
Health Care and Treatment;
Private Sector;
Public Sector;
Alliances;
Problems and Challenges;
Africa;
Botswana
Austin, James E., Diana Barrett, and James Weber. "Merck Global Health Initiatives (B): Botswana." Harvard Business School Case 301-089, January 2001.
- 2001
- Book
Diagnosis Corruption: Fraud in Latin America's Public Hospitals
By: Rafael Di Tella and William D. Savedoff
Di Tella, Rafael, and William D. Savedoff. Diagnosis Corruption: Fraud in Latin America's Public Hospitals. Inter-American Development Bank, 2001.
- 2001
- Chapter
Publicly Funded Science and the Productivity of the Pharmaceutical Industry
By: Rebecca Henderson and Ian Cockburn
U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While...
View Details
Keywords:
Public Sector;
Science-Based Business;
Research and Development;
Sovereign Finance;
Pharmaceutical Industry
Henderson, Rebecca, and Ian Cockburn. "Publicly Funded Science and the Productivity of the Pharmaceutical Industry." In Innovation Policy and the Economy, Volume 1, edited by Adam B. Jaffe, Josh Lerner, and Scott Stern, 1–34. MIT Press, 2001.
- Article
Scale and Scope in Drug Development: Unpacking the Advantages of Size in Pharmaceutical Research
By: Rebecca Henderson and Iain Cockburn
Henderson, Rebecca, and Iain Cockburn. "Scale and Scope in Drug Development: Unpacking the Advantages of Size in Pharmaceutical Research." Journal of Health Economics 20, no. 6 (November 2001).
- December 2000 (Revised January 2001)
- Background Note
Promise of Functional Foods, The
By: Ray A. Goldberg, Carin-Isabel Knoop and Laure Mougeot Stroock
This case presents a definition of functional foods or nutraceuticals (food or food ingredients that could provide a health benefit beyond the traditional nutrients they contain), a description of some of the major obstacles to their commercialization and...
View Details
Keywords:
Food;
Private Sector;
Public Sector;
Health;
Product Development;
Production;
Commercialization;
Food and Beverage Industry;
Pharmaceutical Industry
Goldberg, Ray A., Carin-Isabel Knoop, and Laure Mougeot Stroock. "Promise of Functional Foods, The." Harvard Business School Background Note 901-013, December 2000. (Revised January 2001.)
- 2000
- Chapter
Anticipating Greener Supply Chain Demands: One Singapore Company's Journey to ISO 14001
One major benefit of Jebsen & Jessen Packaging Pte Ltd (JJPS’s) implementation of ISO 14001 is that it acquired a third-party 'seal of approval' that will be used in its marketing efforts to meet the growing environmental concern of its customers within the electronics...
View Details
Keywords:
Supply Chain Management;
Corporate Social Responsibility and Impact;
Standards;
Environmental Sustainability;
Singapore
Toffel, Michael W. "Anticipating Greener Supply Chain Demands: One Singapore Company's Journey to ISO 14001." Chap. 16 in ISO 14001 Case Studies and Practical Experiences, edited by Ruth Hillary, 182–199. Sheffield, U.K.: Greenleaf Publishing, 2000.
- August 2000
- Case
Project ACHIEVE - January 2000
By: H. Kent Bowen and Elizabeth Kind
Education services target public schools to assist the school with technology and services that will improve their communication with students, parents, and the community. There is also the goal of increasing scores of measured learning. How does a small company do...
View Details
Keywords:
Information Technology;
Service Delivery;
Learning;
Interactive Communication;
Measurement and Metrics;
Performance Consistency;
Business and Community Relations;
Expansion;
Technology Adoption;
Education Industry
Bowen, H. Kent, and Elizabeth Kind. "Project ACHIEVE - January 2000." Harvard Business School Case 601-044, August 2000.
- November 1999
- Supplement
"ACT UP": Peter Staley, An Interview with Professor Willis Emmons, November 17, 1995
Provides excerpts from an interview with Peter Staley of Act Up reflecting on the Wall Street protest against Burroughs Wellcome in the fall of 1989 and on the role and impact of AIDS advocacy and activism in general.
View Details
Emmons, Willis M., III. "ACT UP": Peter Staley, An Interview with Professor Willis Emmons, November 17, 1995. Harvard Business School Video Supplement 700-501, November 1999.
- 1999
- Other Unpublished Work
Executive Ownership and Control in Newly Public Firms: The Role of Venture Capitalists
By: Malcolm Baker and Paul Gompers
We study the implications of CEO equity ownership for incentives and control in a sample of 1,011 newly public firms. Before an initial public offering, equity investments by venture capitalists reduce CEO ownership by about half, from an average of 35 percent to 19...
View Details
Keywords:
Equity;
Ownership;
Motivation and Incentives;
Initial Public Offering;
Investment;
Venture Capital;
Managerial Roles;
Cost Management;
Governance Controls;
Executive Compensation
Baker, Malcolm, and Paul Gompers. "Executive Ownership and Control in Newly Public Firms: The Role of Venture Capitalists." November 1999. (First draft in 1998.)
- February 1997 (Revised December 1997)
- Case
Arbor Health Care Company
By: Myra M. Hart and Stephanie Dodson
A venture-funded start-up runs into trouble when health care reimbursement policies change radically. With the help of its board, the company develops a new strategy, becomes profitable, and makes a public offering. The second wave of changes introduced by Clinton...
View Details
Keywords:
Industry Structures;
Growth and Development Strategy;
Management Succession;
Business Startups;
Transformation;
Strategy;
Venture Capital;
Policy;
Initial Public Offering;
Health Industry
Hart, Myra M., and Stephanie Dodson. "Arbor Health Care Company." Harvard Business School Case 897-132, February 1997. (Revised December 1997.)
- April 1996 (Revised June 1999)
- Case
NYPD New
By: James L. Heskett
Police Commissioner Bratten and his staff have led a process designed to create a results-oriented police department from one that previously emphasized and measured effort. With increasing budgeting pressures, the next phase of effort calls for increasing emphasis on...
View Details
Keywords:
Leadership;
Performance Productivity;
Leadership Style;
Budgets and Budgeting;
Public Administration Industry
Heskett, James L. "NYPD New." Harvard Business School Case 396-293, April 1996. (Revised June 1999.)
- Article
Scale and Scope in Drug Development: Unpacking the Advantages of Size in Pharmaceutical Research
By: Rebecca M. Henderson and Iain Cockburn
Henderson, Rebecca M., and Iain Cockburn. "Scale and Scope in Drug Development: Unpacking the Advantages of Size in Pharmaceutical Research." Journal of Health Economics 20, no. 6 (November 2001): 32–59.
- April 1995 (Revised December 2006)
- Case
Identify the Nonprofit
By: Regina E. Herzlinger and Ramona Hilgenkamp
This case presents financial statements and selected ratios for seven unidentified nonprofit organizations and asks that each set of financial information be matched with one of the following nonprofit entities: a public television station, a suburban hospital, a...
View Details
Herzlinger, Regina E., and Ramona Hilgenkamp. "Identify the Nonprofit." Harvard Business School Case 195-215, April 1995. (Revised December 2006.)
- April 1995 (Revised August 1995)
- Case
Empire Blue Cross and Blue Shield (A)
By: Regina E. Herzlinger and Ramona Hilgenkamp
Mounting financial losses and increasing public scrutiny present many challenges to the board of directors of a large nonprofit health insurer. This case series presents chronologically the increasing problems of the company.
View Details
Keywords:
Governing and Advisory Boards;
Corporate Governance;
Financial Condition;
Organizational Culture;
Problems and Challenges;
Nonprofit Organizations;
Insurance Industry
Herzlinger, Regina E., and Ramona Hilgenkamp. "Empire Blue Cross and Blue Shield (A)." Harvard Business School Case 195-216, April 1995. (Revised August 1995.)
- December 1994 (Revised March 1996)
- Case
Ciba Consumer Pharmaceuticals' Acutrim: Challenges and Opportunities in Today's Diet Industry
By: Nancy F. Koehn and Rebecca Voorheis
Since its introduction in 1983, Acutrim has been a major player in the U.S. appetite suppressant market and in the broader diet industry. This case focuses on the strategic, regulatory, marketing, and financial challenges this product and the rapidly changing diet...
View Details
Keywords:
Product Marketing;
Market Design;
Industry Structures;
Public Ownership;
Problems and Challenges;
Opportunities;
Food and Beverage Industry;
Pharmaceutical Industry;
United States
Koehn, Nancy F., and Rebecca Voorheis. "Ciba Consumer Pharmaceuticals' Acutrim: Challenges and Opportunities in Today's Diet Industry." Harvard Business School Case 795-043, December 1994. (Revised March 1996.)
- Article
Measuring Competence? Exploring Firm Effects in Drug Discovery
By: Rebecca M. Henderson and Ian Cockburn
Henderson, Rebecca M., and Ian Cockburn. "Measuring Competence? Exploring Firm Effects in Drug Discovery." Strategic Management Journal 15 (Winter 1994): 63–84. (Winner of Dan and Mary Lou Schendel Best Paper Prize To honor substantial work published in the Strategic Management Journal presented by Strategic Management Society.)
- September 1993 (Revised July 1995)
- Background Note
Public Policy and the Manager: Conceptual Framework
Government intervention in markets may have significant effects--both positive and negative--on a firm's strategic options and its performance outcomes. Thus the ability to analyze the origins, implications, and dynamics of public policy is a critical managerial skill...
View Details
Keywords:
Policy;
Management Skills;
Government and Politics;
Adoption;
Business Strategy;
Performance Evaluation;
Economic Systems
Emmons, Willis M., III. "Public Policy and the Manager: Conceptual Framework." Harvard Business School Background Note 794-028, September 1993. (Revised July 1995.)
- December 1992 (Revised November 1994)
- Case
Becton Dickinson Division: Marketing Organization
The marketing director for the largest division of a health care products company is reviewing the structure and staffing of the division's marketing organization. The division has authorization to hire an additional marketing manager. Hence, the immediate case...
View Details
Keywords:
Business Conglomerates;
Health Care and Treatment;
Human Resources;
Recruitment;
Selection and Staffing;
Managerial Roles;
Product Marketing;
Measurement and Metrics;
Organizational Structure;
Strategy;
Health Industry;
Health Industry
Cespedes, Frank V. "Becton Dickinson Division: Marketing Organization." Harvard Business School Case 593-070, December 1992. (Revised November 1994.)
- September 1991 (Revised February 1993)
- Case
Burroughs Wellcome and AZT (A)
Burroughs Wellcome Co., developer of AZT, the first drug approved by the U.S. Food and Drug Administration for the treatment of Acquired Immune Deficiency Syndrome (AIDS), finds itself under siege in September 1989 by AIDS activists and various segments of the U.S....
View Details
Keywords:
Governing Rules, Regulations, and Reforms;
Ethics;
Business and Government Relations;
Communication Strategy;
Health Care and Treatment;
Monopoly;
Intellectual Property;
Research and Development;
Price;
Pharmaceutical Industry;
London
Emmons, Willis M., III. "Burroughs Wellcome and AZT (A)." Harvard Business School Case 792-004, September 1991. (Revised February 1993.)